NCT00918814View on ClinicalTrials.gov

Dose Ranging and Dose Frequency of LIPO-102

PHASE2CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Subcutaneous Adipose Tissue Reduction

Interventions

DRUG

LIPO-102

Subcutaneous Injection

DRUG

Placebo

Placebo

Trial Locations (2)

Unknown

San Diego

Baltimore

Sponsors

Lead Sponsor

Neothetics, Inc

All Listed Sponsors

lead

Neothetics, Inc

INDUSTRY